Novartis Snaps Up Nestle's Alcon Share For $28.1B
Swiss drug giant Novartis AG revealed plans Monday to gain full ownership of eye care company Alcon Inc. by forking over $28.1 billion for Nestle SA's majority stake and merging with...To view the full article, register now.
Already a subscriber? Click here to view full article